Hospital
Boca Raton Regional Hospital, INC.
Boca Raton Regional Hospital, INC. was paid $2.32M by Medicaid between Jan 2018 and Aug 2024, across 109 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoBOCA RATON REGIONAL HOSPITAL, INC.
BOCA RATON, FL 33486
BOCA RATON, FL 33486
33aNPI1902826779assigned 07/21/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.32M
24GClaims183,159
24DCodes billed109
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#114 of 163
Median peer was paid$4.77M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,819 | $182K | |
| 2019 | 36,760 | $362K | |
| 2020 | 34,412 | $340K | |
| 2021 | 43,911 | $481K | |
| 2022 | 40,597 | $764K | |
| 2023 | 7,479 | $187K | |
| 2024incomplete | 181 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 5,519 | 4,880 | $368K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 6,302 | 5,279 | $310K |
| G0378 | Hospital observation service, per hour | 9.3% | 4,357 | 2,378 | $216K |
| 70450 | Computed tomography, head or brain; without contrast material | 8.7% | 2,485 | 1,950 | $201K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.3% | 4,505 | 3,500 | $146K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.0% | 11,054 | 6,669 | $117K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.8% | 1,039 | 885 | $111K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.7% | 2,270 | 1,311 | $85K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.3% | 2,411 | 1,707 | $77K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.7% | 647 | 515 | $64K |
| 80053 | Comprehensive metabolic panel | 2.2% | 6,722 | 4,227 | $50K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 15,843 | 9,726 | $43K |
97 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 559 | $33K |
| 82962 | 1.3% | 3,380 | $31K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.3% | 4,326 | $29K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 288 | $26K |
| A9270 | Non-covered item or service | <1% | 2,831 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,813 | $20K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,488 | $20K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,069 | $20K |
| 86900 | <1% | 1,653 | $18K | |
| 84484 | <1% | 4,215 | $16K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 892 | $13K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,093 | $12K |
| 86850 | <1% | 1,170 | $12K | |
| 85027 | <1% | 3,823 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,853 | $11K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,083 | $11K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,128 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,359 | $9K |
| 81001 | <1% | 2,878 | $9K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 534 | $9K |
| 82728 | <1% | 649 | $8K | |
| 82550 | <1% | 3,674 | $8K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 60 | $8K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,490 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,961 | $8K |
| 83540 | <1% | 640 | $8K | |
| 82553 | <1% | 3,183 | $8K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 490 | $8K |
| 83735 | <1% | 3,351 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,578 | $7K |
| 85610 | <1% | 4,062 | $7K | |
| 80061 | Lipid panel | <1% | 2,829 | $6K |
| 84100 | <1% | 1,631 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,570 | $5K |
| 83550 | <1% | 514 | $5K | |
| 85730 | <1% | 3,339 | $5K | |
| 87077 | <1% | 1,958 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,839 | $4K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,945 | $4K |
| 87040 | <1% | 1,313 | $3K | |
| 82607 | <1% | 609 | $3K | |
| 97161 | <1% | 437 | $3K | |
| 80076 | <1% | 2,381 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 431 | $3K |
| 83615 | <1% | 131 | $3K | |
| 96376 | <1% | 1,649 | $3K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 550 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 40 | $2K |
| 83690 | <1% | 1,723 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 388 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 164 | $2K |
| 84703 | <1% | 1,582 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 749 | $2K |
| C1769 | Guide wire | <1% | 39 | $2K |
| 83880 | <1% | 1,418 | $2K | |
| 87186 | <1% | 1,182 | $2K | |
| 86901 | <1% | 1,653 | $2K | |
| 87081 | <1% | 223 | $2K | |
| 94664 | <1% | 306 | $2K | |
| 87070 | <1% | 266 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 40 | $1K |
| 82746 | <1% | 171 | $1K | |
| 84238 | <1% | 32 | $1K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 41 | $1K |
| 81003 | <1% | 463 | $1K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 48 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 323 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 684 | $1K |
| 82150 | <1% | 952 | $955.50 | |
| 82565 | <1% | 330 | $822.13 | |
| 76641 | <1% | 37 | $819.35 | |
| 76830 | Ultrasound, transvaginal | <1% | 41 | $672.72 |
| 87205 | <1% | 273 | $473.27 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 13 | $409.22 |
| 83605 | <1% | 277 | $349.52 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 16 | $332.16 |
| 86140 | <1% | 176 | $325.34 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 184 | $297.08 |
| 84702 | <1% | 149 | $239.65 | |
| 87430 | <1% | 263 | $234.70 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 134 | $220.14 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 116 | $152.82 |
| 71250 | <1% | 85 | $100.26 | |
| 85652 | <1% | 336 | $97.78 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 32 | $63.24 |
| 93971 | <1% | 19 | $40.48 | |
| 85379 | <1% | 73 | $25.18 | |
| 84436 | <1% | 37 | $18.31 | |
| 84439 | <1% | 15 | $10.14 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 15 | $5.09 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 31 | $0.65 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 49 | $0.00 |
| 84479 | 0% | 15 | $0.00 | |
| 87420 | 0% | 30 | $0.00 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 41 | $0.00 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 14 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMENDEZ, LINCOLN (CEO)